SLC13A4 and breast cancer: SLC13A4 expression was lower in breast cancer, head and neck squamous cell carcinoma, kidney chromophobe, thyroid cancer, and higher in renal clear cell carcinoma, hepatocellular carcinoma, cholangiocarcinoma, and rectal adenocarcinoma.